In this interview Michel Baijot, CEO of Asit Biotech, discusses what is unique about the company and what newsflow investors can expect from ASIT in the second half of 2019.

23 Jul 2019
ASIT biotech - Executive Interview

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
ASIT biotech - Executive Interview
European Medical Solutions. (ALEMS:BRU) | 0 0 0.0%
- Published:
23 Jul 2019 -
Author:
Dr Andy Smith - Pages:
-
In this interview Michel Baijot, CEO of Asit Biotech, discusses what is unique about the company and what newsflow investors can expect from ASIT in the second half of 2019.